Arthur S. Przybyl
2018
Compensation breakdown
| Non-Equity Incentive Plan | $675,000 |
|---|---|
| Option Awards | $1,104,928 |
| Salary | $726,925 |
| Stock Awards | $1,660,446 |
| Other | $30,634 |
| Total | $4,197,933 |
Przybyl received $1.7M in stock awards, accounting for 40% of the total pay in 2018.
Przybyl also received $675K in non-equity incentive plan, $1.1M in option awards, $726.9K in salary and $30.6K in other compensation.
Rankings
In 2018, Arthur S. Przybyl's compensation ranked 2,606th out of 14,244 executives tracked by ExecPay. In other words, Przybyl earned more than 81.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,606 out of 14,244 | 82nd |
Division Manufacturing | 958 out of 5,765 | 83rd |
Major group Chemicals And Allied Products | 326 out of 2,128 | 85th |
Industry group Drugs | 265 out of 1,817 | 85th |
Industry Pharmaceutical Preparations | 207 out of 1,391 | 85th |
Pay ratio
| Arthur S. Przybyl's Pay | $4,197,933 |
|---|---|
| Median Employee's Pay | $52,389 |
| Pay Ratio | 80to 1 |
In 2018, the annual total compensation of Arthur S. Przybyl was $4,197,933.
The annual total compensation of the median employee at ANI Pharmaceuticals was $52,389.
The ratio of Arthur S. Przybyl's pay to the pay of median employee was therefore 80 to one.
Przybyl's colleagues
We found three more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2018.